Literature DB >> 15663533

Evaluation of improved coronary flow velocity reserve using transthoracic Doppler echocardiography after single LDL apheresis.

Kengo Kobayashi1, Kazuhito Yamashita, Hiromi Tasaki, Hiroshi Suzuka, Shun-ichi Nihei, Kiyoshi Ozumi, Yasuhide Nakashima.   

Abstract

UNLABELLED: The purpose of this study was to clarify whether coronary flow velocity reserve (CFVR), evaluated by adenosine 5'-triphosphate-induced hyperemia, is improved by single low-density lipoprotein (LDL) apheresis. Lipid lowering therapy is known to improve endothelium-dependent vasodilatation in forearm or coronary resistant vessels. However, few reports have studied the effect of acute LDL reduction on CFVR.
METHODS: Seven patients with familial hypercholesterolemia and significant coronary stenosis except in the left anterior descending artery (LAD) were enrolled in this study. Coronary flow velocity reserve was estimated before and after LDL apheresis using transthoracic Doppler echocardiography (TTDE), which detects the flow velocity at the distal site of the LAD. Although the averaged diastolic peak velocity (ADPV) during ATP-induced hyperemia was similar before and after LDL apheresis, the ADPV at baseline decreased from 30.69 to 25.56 cm/s, resulting in an increased CFVR from 1.78 to 2.10 (P < 0.001). Plasma bradykinin and 6 keto PGF1alpha increased while fibrinogen and plasma viscosity decreased after apheresis. Single LDL apheresis improves CFVR according to TTDE analysis because of the decreasing ADPV at baseline, which is thought to be induced by epicardial coronary artery dilatation and improved microvessel function. This is the result of various factors, such as changes in plasma LDL cholesterol, bradykinin and PGI2 levels with LDL apheresis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15663533     DOI: 10.1111/j.1526-0968.2004.00172.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  3 in total

1.  Impaired coronary flow velocity reserve and aortic distensibility in patients with untreated hypercholesterolemia--an echocardiographic study.

Authors:  Attila Nemes; Tamás Forster; Miklós Csanády
Journal:  Int J Cardiovasc Imaging       Date:  2006-06-16       Impact factor: 2.357

2.  Lipoprotein Apheresis Acutely Reverses Coronary Microvascular Dysfunction in Patients With Severe Hypercholesterolemia.

Authors:  Melinda D Wu; Federico Moccetti; Eran Brown; Brian P Davidson; Tamara Atkinson; J Todd Belcik; George Giraud; P Barton Duell; Sergio Fazio; Hagai Tavori; Sotirios Tsimikas; Jonathan R Lindner
Journal:  JACC Cardiovasc Imaging       Date:  2018-06-19

3.  Usefulness of lipid apheresis in the treatment of familial hypercholesterolemia.

Authors:  Matthew Lui; Ross Garberich; Craig Strauss; Thomas Davin; Thomas Knickelbine
Journal:  J Lipids       Date:  2014-10-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.